| |
| Issue |
Title |
| |
| No 3 (2025) |
A personalized approach to the correction of age-dependent endothelial dysfunction in patients with cerebrovascular diseases |
Abstract
PDF (Rus)
|
|
M. V. Putilina |
| |
| No 22 (2024) |
Comparative analysis of the efficacy and safety of non-immunogenic staphylokinase and alteplase in bridging therapy of ischemic stroke |
Abstract
PDF (Rus)
|
|
S. D. Kazakov, D. M. Plotnikov, A. F. Kanev, E. M. Kamenskih, V. M. Alifirova |
| |
| No 12 (2024) |
Repeated ischemic stroke and its prevention |
Abstract
PDF (Rus)
|
|
N. V. Pizova, A. V. Pizov |
| |
| No 12 (2024) |
Arterial hypertension as a global neurological problem and the prospect of multifactorial cerebroprotection: Focus on combination drugs |
Abstract
PDF (Rus)
|
|
M. V. Putilina |
| |
| No 3 (2024) |
Long-term combined antiplatelet therapy for secondary prevention of noncardioembolic stroke |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, L. V. Petrova, M. A. Eneeva |
| |
| No 3 (2024) |
Erratum in the article “Hierarchy of pathogenetic mechanisms of chronic cerebrovascular insufficiency and therapeutic strategies for neuroprotection” |
Abstract
PDF (Rus)
|
|
M V. Putilina |
| |
| No 3 (2024) |
Analysis of satisfaction of stroke patients with medical rehabilitation using multimodal correction technology |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, I. V. Pogonchenkova, L. V. Petrova, A. G. Kashezhev, E. V. Kaverina, M. S. Filippov, K. A. Kozlova |
| |
| No 21 (2023) |
Medical support of rehabilitation of stroke patients: the role of GABA-ergic drugs |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, A. G. Kashezhev, L. M. Petrova, M. A. Eneeva |
| |
| No 21 (2023) |
The duality of asthenia and cognitive impairments in cerebral diseases |
Abstract
PDF (Rus)
|
|
A. B. Lokshina, V. V. Zakharov |
| |
| No 21 (2023) |
Rehabilitation after stroke |
Abstract
PDF (Rus)
|
|
N. A. Pizov |
| |
| No 10 (2023) |
Cryptogenic stroke. Part 4: Antiphospholipid syndrome and cancer |
Abstract
PDF (Rus)
|
|
A. A. Kulesh, A. V. Belopasova, D. A. Demin, S. A. Mekhryakov, L. I. Syromyatnikova, O. I. Vinogradov |
| |
| No 10 (2023) |
Possibilities neuroimaging and neurophysiological research methods to objectify rehabilitation potential in patients with ischemic stroke (analytical review of the literature) |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, A. G. Kashezhev, D. I. Nakhrapov, I. V. Pogonchenkova |
| |
| No 10 (2023) |
The choice of a modern neuroprotective drug as a basic strategy in the treatment of chronic cerebrovascular diseases |
Abstract
PDF (Rus)
|
|
V. N. Shishkova, V. A. Prikhodko, S. V. Okovityi |
| |
| No 3 (2023) |
Involvement immune response in the pathogenesis of ischemic stroke |
Abstract
PDF (Rus)
|
|
S. V. Vorobyev, S. N. Yanishevskiy, I. V. Kudriavtsev, K. M. Shubina, M. S. Antusheva, R. N. Kuznetsova, M. K. Serebriakova, O. V. Petukhova |
| |
| No 3 (2023) |
Hierarchy of pathogenetic mechanisms of chronic cerebrovascular insufficiency and therapeutic strategies for neuroprotection |
Abstract
PDF (Rus)
|
|
M. V. Putilina |
| |
| No 3 (2023) |
Experience with non-immunogenic staphylokinase for intravenous thrombolysis in ischemic stroke: analysis of hospital registry data |
Abstract
PDF (Rus)
|
|
A. A. Kulesh, L. I. Syromyatnikova, S. Krapivin |
| |
| No 21 (2022) |
Comprehensive rehabilitation of patients with post-stroke upper limb dysfunction: a randomized controlled trial |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, L. V. Petrova, I. V. Pogonchenkova, N. V. Neprintseva, S. T. Shurupova |
| |
| No 21 (2022) |
Combined effect of succinic acid, riboxin, nicotinamide, riboflavin for the treatment of chronic brain ischaemia |
Abstract
PDF (Rus)
|
|
M. Yu. Maksimova |
| |
| No 21 (2022) |
Difficulties and prospects of rational therapy of ischemic strokes |
Abstract
PDF (Rus)
|
|
S. A. Zhivolupov, I. N. Samartsev |
| |
| No 21 (2022) |
Cryptogenic stroke. Part 3: atrial cardiopathy and silent atrial fibrillation |
Abstract
PDF (Rus)
|
|
D. A. Demin, A. A. Kulesh, S. N. Yanishevskiy, D. O. Klimchuk, S. A. Mekhryakov, L. I. Syromyatnikova, O. I. Vinogradov, S. A. Chazov |
| |
| No 11 (2022) |
A current view on the prospects for the pharmaceutical therapy in neurorehabilitation after stroke |
Abstract
PDF (Rus)
|
|
V. N. Shishkova, L. A. Kapustina, K. E. Imamgayazova |
| |
| No 2 (2022) |
Neuroinflammation of the brain in stroke in patients with type 2 diabetes mellitus |
Abstract
PDF (Rus)
|
|
S. N. Yanishevskiy, L. S. Onishchenko, E. N. Gnevyshev, O. N. Gaikova, E. V. Yakovlev, A. A. Smirnov |
| |
| No 2 (2022) |
The state of the lumen of the major cerebral vessels and systems of regulation of cerebral circulation in patients with cerebral ischemia with the development of epileptic seizures |
Abstract
PDF (Rus)
|
|
D. R. Khasanova, T. V. Danilova, Z. K. Latypova, G. R. Gainetdinova |
| |
| No 19 (2021) |
Cryptogenic stroke. Part 2: paradoxical embolism |
Abstract
PDF (Rus)
|
|
A. A. Kulesh, D. A. Demin, A. V. Belopasova, S. A. Mekhryakov, O. I. Vinogradov, L. I. Syromyatnikova, A. A. Ziankou |
| |
| No 19 (2021) |
Ménière’s disease and chronic cerebrovascular diseases |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| No 19 (2021) |
Effects of dipyridamole and its use in neurology |
Abstract
PDF (Rus)
|
|
N. V. Pizova |
| |
| No 10 (2021) |
Efficacy and safety of carotid endarterectomy in the acute phase of ischemic stroke |
Abstract
PDF (Rus)
|
|
A. I. Khayrutdinov, Yu. V. Tarasov, D. Kh. Valiullin, V. T. Yakubova, R. N. Komarov, I. N. Shchanitsyn, S. P. Bazhanov |
| |
| No 10 (2021) |
Priorities of medical rehabilitation of patients with recent experience of transient ischemic attack |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, L. V. Petrova, M. A. Eneeva, V. G. Kravchenko |
| |
| No 2 (2021) |
Vestibulo-atactic disorders correction in chronic brain ischemia |
Abstract
PDF (Rus)
|
|
G. N. Belskaya |
| |
| No 8 (2020) |
Acute cerebral circulatory disorders and coronavirus disease |
Abstract
PDF (Rus)
|
|
N. V. Pizova, N. A. Pizov, O. A. Skachkova, M. A. Sokolov, I. A. Izmaylov, R. B. Taramakin |
| |
| No 8 (2020) |
Cognitive and emotional impairment in patients with chronic cerebrovascular insufficiency |
Abstract
PDF (Rus)
|
|
A. B. Bogolepova |
| |
| No 8 (2020) |
Improving the management of patients with a diagnosis of chronic cerebral ischemia |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| No 8 (2020) |
Diagnostics and treatment of chronic cerebral ischemia |
Abstract
PDF (Rus)
|
|
V. V. Zakharov, N. V. Vakhnina, A. G. Gogoleva, S. K. Mezhmidinova |
| |
| No 2 (2020) |
Analysis of immediate and long-term outcomes of perimesencephalic subarachnoid hemorrhage according to the hospital register data |
Abstract
PDF (Rus)
|
|
A. A. Kulesh, V. E. Drobakha, Ju. A. Nurieva, V. V. Shestakov |
| |
| No 2 (2020) |
Cerebral small vessel disease’s impact on the development of chronic cerebral ischemia: paradigms of treatment |
Abstract
PDF (Rus)
|
|
E. Yu. Soloveva, I. P. Amelina |
| |
| No 18 (2019) |
Ischemic stroke and antithrombotic therapy: key aspects |
Abstract
PDF (Rus)
|
|
M. Yu. Maksimova, A. V. Fonyakin, L. A. Geraskina |
| |
| No 18 (2019) |
The use of melatonin as a neuroprotector in the therapy of ischemic stroke |
Abstract
PDF (Rus)
|
|
M. G. Poluektov, A. M. Narbut, N. A. Shuvakhina |
| |
| No 18 (2019) |
Experience of using vasoactive therapy in patients with stage I-II venous discirculatory encephalopathy |
Abstract
PDF (Rus)
|
|
G. N. Bel’skaya, S. B. Stepanova, I. G. Lukashevich, E. I. Luzanova |
| |
| No 9 (2019) |
Transient ischemic attacks: their importance in the progression of cerebrovascular diseases and topical issues of medical rehabilitation |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, L. V. Petrova |
| |
| No 9 (2019) |
Combination and mutual effect of Alzheimer’s disease and cerebrovascular disease |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| No 9 (2019) |
Treatment of comorbid patients with chronic brain ischemia and vertebrogenic pain syndromes |
Abstract
PDF (Rus)
|
|
V. V. Zakharov, V. V. Grinyuk, N. V. Vakhnina, E. Yu. Kalimeeva |
| |
| No 1 (2019) |
Pathophysiological features of chronic cerebrovascular diseases and possibilities of complex neuroprotective therapy |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, L. V. Petrova |
| |
| No 18 (2018) |
Chronic cerebrovascular diseases: pathogenetic heterogeneity and therapeutic strategies |
Abstract
PDF (Rus)
|
|
E. V. Kostenko, M. A. Eneeva |
| |
| No 18 (2018) |
Diagnosis and treatment of chronic cerebral ischemia (clinical discussion) |
Abstract
PDF (Rus)
|
|
V. V. Zakharov, N. V. Vakhnina |
| |
| No 9 (2018) |
Diagnosis and treatment of chronic cerebral ischemia. DIAMANT study results |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| No 9 (2018) |
The effect of cellex on the recovery of motor and speech functions during early neurorehabilitation of patients with ischemic stroke |
Abstract
PDF (Rus)
|
|
D. P. Khasanova, T. V. Danilova, T. V. Demin, K. S. Knni, L. V. Gaifutdinova |
| |
| No 17 (2017) |
MANAGEMENT OF PATIENTS AFTER ISCHEMIC STROKE WITH MOTOR DISTURBANCES |
Abstract
PDF (Rus)
|
|
V. A. Parfenov |
| |
| No 17 (2017) |
МЕСТО СИМПТОМАТИЧЕСКОЙ ТЕРАПИИ НЕДОСТАТОЧНОСТИ МОЗГОВОГО КРОВООБРАЩЕНИЯ В РЕАЛЬНОЙ ПРАКТИКЕ. МНЕНИЯ СПЕЦИАЛИСТОВ (ПО МАТЕРИАЛАМ КРУГЛОГО СТОЛА) |
Abstract
PDF (Rus)
|
|
|
| |
| No 10 (2017) |
ATRIAL FIBRILLATION IN PATIENTS WITH HEMORRHAGIC STROKE: APPROACHES TO ANTICOAGULANT THERAPY |
Abstract
PDF (Rus)
|
|
A. M. Kulagina, A. V. Zorina, O. I. Vinogradov |
| |
| No 10 (2017) |
HYPERHOMOCYSTEINEMIA AND ISCHEMIC STROKE |
Abstract
PDF (Rus)
|
|
N. V. Pizova, N. A. Pizo |
| |
| No 8 (2016) |
Антикоагулянтная терапия в неврологии. По материалам Всероссийского форума антикоагулянтной терапии |
Abstract
PDF (Rus)
|
|
Editorial Article |
| |
| No 8 (2016) |
Integrated rehabilitation for patients with post-stroke syndrome |
Abstract
PDF (Rus)
|
|
D. R. Khasanova, Y. V. Zhitkova, I. I. Tabiev |
| |
| No 8 (2016) |
Antiplatelet therapy as an element of primary and secondary prevention of ischemic stroke |
Abstract
PDF (Rus)
|
|
E. Y. Solovyova, E. D. Dzhutova, E. A. Tyutyumova |
| |
| No 11 (2016) |
POST-STROKE MOTOR DISTURBANCES |
Abstract
PDF (Rus)
|
|
V. A. PARFENOV |
| |
| No 11 (2016) |
CRYPTOGENIC STROKE IN GENERAL PRACTICE |
Abstract
PDF (Rus)
|
|
D. A. NAPALKOV, A. A. SOKOLOVA, E. A. SON, S. R. BELOUSOV, V. A. OSADCHAYA, A. I. LAVROVA, A. Y. LENKOVSKAYA, A. S. SHOIKHET, I. L. TSAREV |
| |
| No 11 (2016) |
SECONDARY PREVENTION OF ISCHEMIC STROKE AND COGNITIVE IMPAIRMENT |
Abstract
PDF (Rus)
|
|
V. A. PARFYONOV, S. V. VERBITSKAYA |
| |
| No 11 (2016) |
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE |
Abstract
PDF (Rus)
|
|
G. N. BELSKAYA, N. V. PIZOVA, M. A. SOKOLOV, I. A. IZMALOV |
| |
| No 11 (2016) |
MELDONIUM EFFICACY IN CHRONIC CEREBROVASCULAR DISEASES |
Abstract
PDF (Rus)
|
|
M. A. DOMASHENKO, M. Yu. MAKSIMOVA |
| |
| No 10 (2015) |
Intra-arterial reperfusion therapy in patients with acute ischemic stroke |
Abstract
PDF (Rus)
|
|
M. Y. Volodyuhin, D. R. Khasanova, T. V. Demin, B. I. Zagidullin, S. G. Musin, M. R. Sharafutdinov |
| |
| No 18 (2015) |
Citicoline for ischemic stroke: from acute phase to rehabilitation |
Abstract
PDF (Rus)
|
|
D. V. Sergeev, M. A. Domashenko, M. A. Piradov |
| |
| No 18 (2015) |
Modern aspects of diagnosis and treatment of chronic cerebral ischemia. Application of naftidrofuryl |
Abstract
PDF (Rus)
|
|
V. A. Parfyonov |
| |
| No 18 (2015) |
Current prospects for higher effectiveness of ischemic stroke management |
Abstract
PDF (Rus)
|
|
G. N. Belskaya, E. I. Luzanova, L. D. Makarova, S. B. Stepanova, D. A. Sergienko |
| |
| No 5 (2015) |
Antiplatelet therapy in secondary prevention of ischemic stroke |
Abstract
PDF (Rus)
|
|
V. A. Parfyonov, S. V. Verbitskaya |
| |
| No 5 (2015) |
Experience with mildronate in cerebrovascular diseases |
Abstract
PDF (Rus)
|
|
N. V. Pizova |
| |
| No 5 (2014) |
Secondary ischemic stroke prevention in patients with atrial fibrillation: results of the ROCKET AF study |
Abstract
PDF (Rus)
|
|
V. A. Parfyonov, S. V. Verbitskaya |
| |
| No 5 (2014) |
Role of clopidogrel role in secondary prevention of ischemic stroke |
Abstract
PDF (Rus)
|
|
K. S. Meshkova, V. V. Gudkova |
| |
| 1 - 66 of 66 Items |
|
